CONMED News

The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.60 per share, which is equivalent to a dividend yield of approximately 2.2 percent based on the closing price of CONMED's stock as of May 21, 2012.

"CONMED has been energizing therapeutic endoscopy and provided important medical solutions to the global GI community for over 20 years," said Mark Donovan, Vice President of the CONMED Endoscopic Technologies business unit.

Shares of CONMED traded up 1.20% during mid-day trading on Monday, hitting $27.84. CONMED has a one year low of $20.51 and a one year high of $31.94. The company has a market cap of $787.6 million and a P/E ratio of 450.98. CONMED last issued its quarterly earnings data on Thursday, April 26th.

"CONMED is off to a solid start in 2012 with double digit earnings growth and a sales increase of approximately six percent.

Financial and Strategic SWOT Analysis Review Summary CONMED Corporation is a global medical technology company engaged in the development and marketing of surgical instruments and devices used for minimally invasive procedures and monitoring.